Dermapharm Holding SE (ETR:DMP)
35.65
-0.55 (-1.52%)
At close: Jan 23, 2026
Dermapharm Holding SE Employees
Dermapharm Holding SE had 3,610 employees as of December 31, 2024. The number of employees increased by 113 or 3.23% compared to the previous year.
Employees
3,610
Change (1Y)
113
Growth (1Y)
3.23%
Revenue / Employee
€325,248
Profits / Employee
€32,142
Market Cap
1.92B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3,610 | 113 | 3.23% |
| Dec 31, 2023 | 3,497 | 934 | 36.44% |
| Dec 31, 2022 | 2,563 | 190 | 8.01% |
| Dec 31, 2021 | 2,373 | 62 | 2.68% |
| Dec 31, 2020 | 2,311 | 458 | 24.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Gerresheimer AG | 12,142 |
| Carl Zeiss Meditec AG | 5,784 |
| SCHOTT Pharma AG & Co. KGaA | 4,811 |
Dermapharm Holding SE News
- 18 days ago - EQS-DD: Dermapharm Holding SE: Christof Dreibholz, buy - Wallstreet:Online
- 6 weeks ago - EQS-DD: Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy - Wallstreet:Online
- 2 months ago - EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 2 months ago - EQS-DD: Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy - Wallstreet:Online
- 5 months ago - Dermapharm's Steady Growth: H1 Stability & Q2 EBITDA Boost - Wallstreet:Online
- 5 months ago - EQS-News: Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter - Wallstreet:Online
- 5 months ago - EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 5 months ago - Dermapharm Holding SE: On Track for Growth in Q2 2025! - Wallstreet:Online